Search Results

There are 4848 results for: content related to: Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer

  1. Celecoxib for osteoarthritis

    Intervention Review

    The Cochrane Library

    Livia Puljak, Ana Marin, Davorka Vrdoljak, Filipa Markotic, Ana Utrobicic and Peter Tugwell

    Published Online : 22 MAY 2017, DOI: 10.1002/14651858.CD009865.pub2

  2. Celecoxib for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Mahir Fidahic, Antonia Jelicic Kadic, Mislav Radic and Livia Puljak

    Published Online : 9 JUN 2017, DOI: 10.1002/14651858.CD012095.pub2

  3. You have free access to this content
    Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels

    British Journal of Pharmacology

    Volume 164, Issue 6, November 2011, Pages: 1722–1737, XN Du, X Zhang, JL Qi, HL An, JW Li, YM Wan, Y Fu, HX Gao, ZB Gao, Y Zhan and HL Zhang

    Version of Record online : 24 OCT 2011, DOI: 10.1111/j.1476-5381.2011.01483.x

  4. You have free access to this content
    Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors

    International Journal of Cancer

    Volume 118, Issue 2, 15 January 2006, Pages: 396–404, Madhu Sudhan Shaik, Abhijit Chatterjee, Tanise Jackson and Mandip Singh

    Version of Record online : 28 JUL 2005, DOI: 10.1002/ijc.21325

  5. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations

    Journal of Pharmaceutical Sciences

    Volume 96, Issue 10, October 2007, Pages: 2686–2702, Héctor R. Guzmán, Mark Tawa, Zhong Zhang, Pasut Ratanabanangkoon, Paul Shaw, Colin R. Gardner, Hongming Chen, Jean-Pierre Moreau, Örn Almarsson and Julius F. Remenar

    Version of Record online : 22 MAY 2007, DOI: 10.1002/jps.20906

  6. PDE5 Inhibitors Enhance Celecoxib Killing in Multiple Tumor Types

    Journal of Cellular Physiology

    Volume 230, Issue 5, May 2015, Pages: 1115–1127, Laurence Booth, Jane L. Roberts, Nichola Cruickshanks, Seyedmehrad Tavallai, Timothy Webb, Peter Samuel, Adam Conley, Brittany Binion, Harold F. Young, Andrew Poklepovic, Sarah Spiegel and Paul Dent

    Version of Record online : 28 JAN 2015, DOI: 10.1002/jcp.24843

  7. You have free access to this content
    Mechanisms of Kv2.1 channel inhibition by celecoxib – modification of gating and channel block

    British Journal of Pharmacology

    Volume 159, Issue 2, January 2010, Pages: 405–418, RV Frolov, VE Bondarenko and S Singh

    Version of Record online : 15 DEC 2009, DOI: 10.1111/j.1476-5381.2009.00539.x

  8. You have full text access to this OnlineOpen article
    TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB

    EMBO Molecular Medicine

    Volume 9, Issue 12, December 2017, Pages: 1660–1680, Shih-Chia Huang, Pei-Chi Wei, Wendy W Hwang-Verslues, Wen-Hung Kuo, Yung-Ming Jeng, Chun-Mei Hu, Jin-Yuh Shew, Chiun-Sheng Huang, King-Jen Chang, Eva Y-HP Lee and Wen-Hwa Lee

    Version of Record online : 9 OCT 2017, DOI: 10.15252/emmm.201606914

  9. You have full text access to this Open Access content
    EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma

    Cancer Science

    Volume 100, Issue 5, May 2009, Pages: 961–969, Xuejun Hong, Yang Liu, Guili Hu, Dekuang Zhao, Jiangen Shen, Fenping Shen, Xuetao Cao and Qingqing Wang

    Version of Record online : 24 MAR 2009, DOI: 10.1111/j.1349-7006.2009.01129.x

  10. Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-Independent Manner

    Journal of Cellular Biochemistry

    Volume 108, Issue 1, 1 September 2009, Pages: 181–194, Wenhong Xia, Tao Zhao, Jinghuan Lv, Shan Xu, Junfeng Shi, Shui Wang, Xiao Han and Yujie Sun

    Version of Record online : 26 JUN 2009, DOI: 10.1002/jcb.22239

  11. You have full text access to this OnlineOpen article
    Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway

    Cancer Science

    Volume 108, Issue 1, January 2017, Pages: 108–115, Issei Egashira, Fumi Takahashi-Yanaga, Risa Nishida, Masaki Arioka, Kazunobu Igawa, Katsuhiko Tomooka, Yoshimichi Nakatsu, Teruhisa Tsuzuki, Yusaku Nakabeppu, Takanari Kitazono and Toshiyuki Sasaguri

    Version of Record online : 1 DEC 2016, DOI: 10.1111/cas.13106

  12. Cancer cell killing by Celecoxib: Reality or just in vitro precipitation-related artifact?

    Journal of Cellular Biochemistry

    Volume 114, Issue 6, June 2013, Pages: 1434–1444, Andrea Sacchetti

    Version of Record online : 16 APR 2013, DOI: 10.1002/jcb.24485

  13. You have full text access to this Open Access content
    Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity

    Aging Cell

    Volume 10, Issue 3, June 2011, Pages: 506–519, Tsui-Ting Ching, Wei-Chung Chiang, Ching-Shih Chen and Ao-Lin Hsu

    Version of Record online : 7 APR 2011, DOI: 10.1111/j.1474-9726.2011.00688.x

  14. N-succinylaspart-1-yl celecoxib is a potential colon-specific prodrug of celecoxib with improved therapeutic properties

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 5, May 2012, Pages: 1831–1842, Yonghyun Lee, Jeongyun Kim, Hyunjeong Kim, Sookjin Kang, Jeong-Hyun Yoon, Dae-Duk Kim, Young Mi Kim and Yunjin Jung

    Version of Record online : 14 FEB 2012, DOI: 10.1002/jps.23082

  15. You have free access to this content
    Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment

    Cellular Microbiology

    Volume 10, Issue 6, June 2008, Pages: 1235–1248, Stephanie Weibel, Jochen Stritzker, Matthias Eck, Werner Goebel and Aladar A. Szalay

    Version of Record online : 18 JAN 2008, DOI: 10.1111/j.1462-5822.2008.01122.x

  16. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib

    Molecular Carcinogenesis

    Volume 48, Issue 1, January 2009, Pages: 56–65, Huahong Xie, Liucun Gao, Na Chai, Jiugang Song, Jun Wang, Zhenshun Song, Caiping Chen, Yanglin Pan, Lina Zhao, Shiren Sun, Kaichun Wu, Mark A. Feitelson, Jie Liu and Daiming Fan

    Version of Record online : 27 MAY 2008, DOI: 10.1002/mc.20455

  17. Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat

    Liver International

    Volume 30, Issue 7, August 2010, Pages: 969–978, Enrique Chávez, José Segovia, Mineko Shibayama, Victor Tsutsumi, Paula Vergara, Luis Castro-Sánchez, Eduardo Pérez Salazar, Mario G. Moreno and Pablo Muriel

    Version of Record online : 26 MAY 2010, DOI: 10.1111/j.1478-3231.2010.02256.x

  18. You have free access to this content
    Celecoxib inhibits meningioma tumor growth in a mouse xenograft model


    Volume 109, Issue 3, 1 February 2007, Pages: 588–597, Brian T. Ragel, Randy L. Jensen, David L. Gillespie, Stephen M. Prescott and William T. Couldwell

    Version of Record online : 18 DEC 2006, DOI: 10.1002/cncr.22441

  19. Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways

    Experimental Dermatology

    Volume 18, Issue 11, November 2009, Pages: 939–946, Smita Agarwal, Chandrani Achari, D. Praveen, Karnati R. Roy, Gorla Venkateswara Reddy and Pallu Reddanna

    Version of Record online : 24 JUN 2009, DOI: 10.1111/j.1600-0625.2009.00874.x

  20. Antiangiogenic and Chemopreventive Activities of Celecoxib in Oral Carcinoma Cell

    The Laryngoscope

    Volume 112, Issue 5, May 2002, Pages: 839–843, Zhi Wang, Cesar F. Fuentes and Stanley M. Shapshay

    Version of Record online : 2 JAN 2009, DOI: 10.1097/00005537-200205000-00012